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Introduction
Endometrial cancer is one of the most common gyneco-
logic malignancies. In the United States, it is estimated
that there are 42,100 annual new cases and 7,400
deaths resulting from this disease [1]. In Taiwan, the
incidence of endometrial cancer has increased rapidly;
it affected approximately 250 women in 1995, 418
women in 2000, and approximately 1,100 in 2007,
according to the Taiwan Society of Cancer Registry.
The trend has shown an increasing application of
minimally invasive techniques in the surgery of gyneco-
logic cancer to minimize morbidity and recovery time.
Since the early 1990s when Childers et al demon-
strated the feasibility of laparoscopic-assisted surgical
staging of endometrial cancer [2–4], this approach has
been increasingly utilized by gynecologic oncologists
[3]. However, laparoscopic cancer surgery was still
limited by technique barriers of a high learning curve,
long operation time, and limitations in performing
complex surgical procedures [5].
The da Vinci Surgical System (Intuitive Surgical,
Inc., Sunnyvale, CA, USA) has been reported to over-
come some technical difficulties in traditional laparo-
scopic hysterectomy; however, its application for staging 
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surgery of endometrial cancer is still relatively new [6–8].
Currently, we are the first institute to establish a pro-
gram of robot-assisted laparoscopic staging surgery for
endometrial cancer in Taiwan. The present study aims
to evaluate the outcomes of the surgical procedures and
the feasibility of this robotic surgery program.
Materials and Methods
A retrospective chart review was carried out for patients
of endometrial cancer with the intention to treat the
disease with robot-assisted laparoscopic staging sur-
gery procedures at the Chang Gung Memorial Hospital
between July 2007 and August 2008. All patients gave
their written informed consent, and all procedures were
performed by the senior author (Dr C.L. Lee).
Operation procedure
After general anesthesia, the patient was placed in the
low lithotomy position with arms padded and tucked
in. Once pneumoperitoneum was achieved, the patient
was placed in a steep Trendelenburg position, and all
ports were placed (to be described). The patient-side
cart (of the da Vinci Surgical System) was then driven
between the patient’s legs, and each responsible port
was docked onto the assigned robotic arms, except for
the ones operated by the assistant surgeon standing at
the left side of the patient.
Trocar placement
Four or five ports were used as shown in the Figure. 
A primary puncture of a 12-mm port for the laparoscope
was placed at the Lee-Huang point [9], which was
placed 3–5 cm above the umbilicus. Two 8-mm ports
were placed at the level of the umbilicus and 10–12 cm
laterally on either side and docked onto the robotic
arms. A fourth puncture, which was a 12-mm port
placed between the laparoscope and the left 
robotic port, was for the assistant surgeon who was in
charge of suction, irrigation, exposing the field, intro-
ducing sutures, and removing specimens. For complex
cases, a fifth 10-mm port was placed between the pri-
mary and the right robotic port for handling of power-
ful vasculature sealing instruments, such as the 10-mm
Ligasure Atlas (Valleylab, Covidien) or EndoGIA (Auto
Suture, Covidien).
Instrumentation
A zero-degree endoscope was used for the entire pro-
cedure. We used an EndoWrist plasma-kinetic bipolar
grasper in the left robotic hand and EndoWrist monopo-
lar curved scissors in the right hand (Intuitive Surgical
Inc., Sunnyvale, CA, USA). A Koh colpotomizer and
RUMI uterine manipulator (Cooper Surgical, Pleasanton,
CA, USA) were used to identify the vaginal fornices
during hysterectomy. The uterine balloon was filled
with 5 mL sterile saline, and a vaginal colpo-pneumo
occluder balloon was filled with 60–100 mL of air.
Lymphadenectomy
Once the whole abdominal cavity was surveyed and
washing cytology obtained, the retroperitoneal space
was explored by incising the peritoneum overlying the
psoas muscle from the pelvic brim to the round liga-
ment, in a direction lateral and parallel to the infundi-
bulopelvic ligament using sharp dissection via bilateral
robotic hands. After identification of the pelvic vessels
and ureters, dissection of lymph nodes began from the
bifurcation of the common iliac vessels to the crossover
of the deep circumflex iliac vein over the external iliac
artery. The obturator space was exposed by lateral re-
traction of the external iliac vein, and lymphatic tissues
were dissected from posterior attachment to the external
iliac vein and lateral attachment to the pelvic sidewall
to the obturator nerve. Para-aortic lymphadenectomy
began by incising the peritoneum from the bifurcation of
the aorta to the level of the inferior mesenteric artery,
and the lymphatic tissue overlying the aorta and vena
cava was removed. All nodal tissue was retrieved in 
an endobag to avoid contact with the abdominal wall.
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Figure. Sketch demonstrating the location of trocar place-
ment. Four or five trocars were inserted as follows: (1) the
primary trocar was at the Lee-Huang point (3–5 cm above
the umbilicus) and was for laparoscopic camera insertion;
(2) & (3) two 8-mm ports 10–12 cm lateral to the umbilicus
on either side were for the robotic arms and instruments; (4)
an accessory port was for the assistant surgeon standing at
the left side of the patient; and (5) in complex cases, an
additional port was established.
It was not necessary to change to different EndoWrist
instruments during the lymphadenectomy.
Hysterectomy
All robot-assisted laparoscopic hysterectomy performed
in this series was type IVE according to the American
Association of Gynecologic Laparoscopists classification
system, which meant that there was total laparoscopic
removal of the uterus and cervix including vaginal cuff
closure [10]. Vascular pedicles were taken with a plasma-
kinetic bipolar cautery and transected with a monopo-
lar cautery. A circumferential colpotomy was performed
with monopolar scissors on the superior margin of the
Koh ring, and vaginal closure was performed using 0
Vicryl sutures on CT-1 needles with a continuous non-
running lock technique using the needle driver on the
right arm and plasma-kinetic bipolar grasper remaining
on the left arm.
Data analysis
Patient demographics, intraoperative findings, post-
operative outcomes, and pathologic reports were all
prospectively recorded as patients enrolled in the study.
Feasibility of the program was evaluated with parame-
ters of surgical procedures and outcomes, including
docking time, operation time, estimated blood loss,
length of hospital stay, intraoperative and postopera-
tive complications, and number of lymph nodes re-
trieved. Robot docking-time was defined as the time
from the robot advancing to the patient to the time
that all ports were connected to robotic arms. Opera-
tion time was counted from the complete docking 
of the robot to skin closure at the end of surgery. Age
and body mass index were considered as continuous
variables, while parity and the number of lymph nodes
retrieved were considered as discrete variables. Nor-
mality testing of data distribution was performed with
the Kolmogorov-Smirnov test in which data with nor-
mal distributions are presented as mean ± standard
deviation, while data without normal distributions are
presented as median value and range. Incidence is pre-
sented as a percentage.
Results
From July 2007 to August 2008, six patients with endo-
metrial cancer, with a mean age of 47.5 ± 1.4 years 
and mean body mass index of 26.2 ± 3.5 kg/m2, were
recruited and underwent robot-assisted procedures
completely without conversion to traditional laparos-
copy or laparotomy. The demographic background of
the patients is listed in Table 1.
All the robot-assisted surgeries completed the 
staging surgery procedures, including collecting wash-
ing cytology, total laparoscopic hysterectomy, bilateral
salpingo-oophorectomy, and bilateral pelvic/para-aortic
lymphadenectomy. For preparation of the robot, the
mean docking time was 45.0 ± 13.6 minutes and the
robot-assisted operation time was 200.3±30.0 minutes.
The mean estimated blood loss was 180.0 ± 147.6 mL
throughout the procedure. No blood transfusions were
administered in the present series. All patients were dis-
charged on the third day after the operation (Table 2).
The results of the pathologic examination are listed
in Table 3 and the staging was based on the Interna-
tional Federation of Gynecology and Obstetrics (FIGO)
system. The final pathology revealed three patients with
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Table 1. Patient demographics
Case
Age Weight Height BMI 
(yr) (g) (cm) (kg/m2)
1 50 59.6 158.0 24
2 46 60.0 149.5 27
3 47 56.8 157.0 23
4 47 58.6 158.0 23
5 48 63.0 150.0 28
6 47 86.4 165.0 32
BMI = body mass index.
Table 2. Intraoperative data
Case Robotic procedure
Docking time Op. time EBL 
Complication
(min) (min) (mL)
1 Washing cytology + BPLD/PALD + BSO + TLH 67 242 100 Neg
2 Washing cytology + BPLD/PALD + BSO + TLH 52 220 300 Neg
3 Washing cytology + BPLD/PALD + BSO + TLH 48 213 30 Neg
4 Washing cytology + BPLD/PALD + BSO + TLH 37 180 50 Neg
5 Washing cytology + BPLD/PALD + BSO + TLH 29 160 200 Neg
6 Washing cytology + BPLD/PALD + BSO + TLH 37 187 400 Neg
BPLD = bilateral pelvic lymph node dissection; PALD = para-aortic lymph node dissection; BSO = bilateral salpingo-oophorectomy; TLH = total laparoscopic 
hysterectomy American Association of Gynecologic Laparoscopists Class IV-E; Op. time = operation time; EBL = estimated blood loss; Neg = negative.
atypical complex hyperplasia with focal endometrioid
adenocarcinoma, two patients with well-differentiated
endometrioid adenocarcinoma, and one patient with
moderately differentiated endometrioid carcinoma with
stromal invasion and with ovarian microscopic metas-
tasis (FIGO stage IIIa), who subsequently underwent
radiotherapy after the operation. The mean number of
lymph nodes retrieved was 23.2 ± 7.4. All patients were
alive and disease free up to the date of this report,
with a median follow-up of 6.5 months (range, 5–17
months). No complications, port-site metastases, or
recurrences occurred in the present series.
Discussion
Because of the avoidance of a long abdominal incision,
laparoscopic surgery offers advantages of reduced post-
operative morbidity, shorter hospital stay, and rapid
recovery. Many investigators have advocated endoscopic
approaches in cancer surgery [11–13]. In a prospective
randomized trial of laparoscopy versus laparotomy for
the comprehensive surgical staging surgery of endome-
trial cancer, which enrolled 2,616 women, laparoscopic
surgical staging surgery was feasible for most women
with clinical stage I-IIA uterine cancer (Gynecologic
Oncology Group-LAP2) [14]. However, a review of en-
dometrial cancer treated in California from 1997 to
2001 revealed that only 8% of patients underwent this
minimally-invasive surgical approach [15]. Reasons for
this lack of application include difficulties in training
and mastery of the surgical procedures, a prolonged
operation time, physical demands of non-ergonomic
surgery, and concerns of individual surgeons about the
efficacy and safety of laparoscopic lymphadenectomy.
Although the advantages have not yet been estab-
lished, robot-assisted laparoscopic surgery using the
da Vinci surgical system overcomes many difficulties in
standard laparoscopic procedures because of improve-
ments in optics, ergonomics, and wristed-motion instru-
mentation that enables the improvement of precision
and control [16]. The first total robotic hysterectomy
was reported by Diaz-Arrastia et al in 2002 [17]. They
reported 41 patients who underwent robot-assisted
laparoscopic surgeries with 20 patients who had en-
dometrial, ovarian, or cervical cancer. The overall data
showed little estimated blood loss (253 mL), short hos-
pital stay (average, 2.5 days), a low overall complica-
tion rate of 7.3%, and no laparoconversion [18].
There are few reports of robot-assisted surgeries for
endometrial cancer. Table 4 lists the comparisons of our
preliminary results with the published data [19–24].
The average body mass indices range from 26.1 to 35.3,
and the mean operation times range from 3 hours to 
4 hours. The estimated blood loss ranges from 63 mL
to 180 mL. The mean lymph nodes retrieved varies in 
a wide range from 10.4 to 29.8. Some studies reported
a range of complication rates from 3.6% to 7.5%; how-
ever, there were no complications in our series.
There was an unavoidable learning curve. In the
present series, the robot-assisted operation times were
longer than those in earlier cases but this later de-
creased, although statistical significance was not seen.
A similar trend was found in the number of lymph nodes
retrieved, which was the most important parameter
for the completeness of lymphadenectomy. Except for
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Table 3. Pathologic examination and postoperative course
Case Pathology Grade Cytology
Node FIGO Adjuvant Disease Follow up 
yield stage theraphy status (mo)
1 Atypical complex hyperplasia with 1 Neg 9 Ia Megace (40) NED 17
focal endometrioid adenocarcinoma 1# qd for 1 yr
2 Atypical complex hyperplasia with 1 Neg 25 Ia None NED 16
focal endometrioid adenocarcinoma
3 Well-differentiated endometrioid 1 Neg 27 Ia None NED 7
adenocarcinoma
4 Well-differentiated endometrioid 1 Neg 30 Ia Megace (40) 1# qd NED 6
adenocarcinoma
5 Moderately differentiated 2 Neg 22 IIIa Radiotherapy: true NED 5
endometrioid adenocarcinoma and pelvis 5,040 cGy, 
stromal invasion with left ovarian Vagina: 200 cGy
microscopic metastasis
6 Atypical complex hyperplasia with 1 Neg 26 Ia Megace (40) 1# qd NED 5
focal endometrioid adenocarcinoma
FIGO = International Federation of Gynecology and Obstetrics; NED = no evidence of disease; Neg = negative.
the first case, the yields of lymph-node number were
more than 22 in the last five cases, which showed that
this was adequate for lymphadenectomy in robotic
surgery. One of the reasons for these findings could be
because all the procedures were performed by the same
senior endoscopist serving as a console surgeon and
the same junior endoscopic surgeon served as an assis-
tant. This could have allowed a rapid accumulation of
experience throughout the preparation and handling
of the procedures, to facilitate a rapid familiarity and
competence of the surgical technique. Our docking time
also decreased after establishment of the paramedical
“robotic surgery team”, which was composed of senior
circulating and scrub nurses. The team’s ability to cali-
brate, apply sterile draping, and facilitate docking of the
robot was greatly improved after gaining experience.
There are several obvious disadvantages in robot-
assisted laparoscopy compared with traditional laparos-
copy and laparotomy. It took much longer to prepare
for the surgical procedure, especially for the set up and
docking of the robotic system. Even after improvement
of preparation and docking procedures, it still took
more than 30 minutes. The cost is also much more ex-
pensive than that of laparoscopy and laparotomy. To
reduce the cost, we only used three types of EndoWrist
instruments (monopolar curved scissors, a plasma-
kinetic bipolar grasper, and needle driver) during the
whole procedure.
In conclusion, for patients with endometrial cancer,
robot-assisted laparoscopic staging surgery appears to
be a safe and effective surgical treatment, which allows
an easier and more comprehensive lymphadenectomy,
overcoming the technical limitations found in conven-
tional laparoscopy, and improving the staging surgery
process for endometrial cancer. These advantages con-
tributed to the minimal invasiveness in surgical treatment
for uterine cancer. However, the high cost of robotic
surgery is a concern for increasing medical expenses.
Larger multi-institutional studies with long-term follow-
up are needed to confirm our preliminary findings.
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